Opposing effects of retinoic acid and dexamethasone on cellular retinol-binding protein ribonucleic acid levels in the rat

Endocrinology. 1991 Aug;129(2):705-9. doi: 10.1210/endo-129-2-705.


Cellular retinol-binding protein (CRBP) is a potential mediator of vitamin A action. To determine whether retinoic acid and dexamethasone administration, alone and in combination, influence CRBP gene expression, adult female vitamin A-sufficient Sprague-Dawley rats randomly received 1) all-trans retinoic acid (100 micrograms) by intragastric intubation, 2) dexamethasone (2 micrograms/g BW) by ip injection, or 3) both all-trans retinoic acid and dexamethasone in the same doses. Control animals received either cottonseed oil by intragastric intubation or saline by ip injection. Six hours after treatment, lung and liver tissue were collected for Northern blot analysis with the radiolabeled cDNA specific for rat CRBP. Retinoic acid administration increased the amount of lung CRBP mRNA only, whereas dexamethasone decreased both lung and liver CRBP mRNA abundance. In animals treated with both retinoic acid and dexamethasone, CRBP mRNA abundance was also reduced. We conclude that CRBP gene expression can be modulated by both retinoic acid and dexamethasone in the vitamin A-sufficient animal. In the whole animal, our findings indicate that dexamethasone not only represses CRBP gene expression, but also opposes the effect of retinoic acid.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • DNA Probes
  • Dexamethasone / pharmacology*
  • Female
  • Gene Expression / drug effects*
  • Liver / metabolism
  • Lung / metabolism
  • Nucleic Acid Hybridization
  • RNA, Messenger / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Retinol-Binding Proteins / genetics*
  • Retinol-Binding Proteins, Cellular
  • Tretinoin / pharmacology*


  • DNA Probes
  • RNA, Messenger
  • Retinol-Binding Proteins
  • Retinol-Binding Proteins, Cellular
  • Tretinoin
  • Dexamethasone